MedPath

Innovus Pharmaceuticals, Inc.

Innovus Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2010-01-01
Employees
27
Market Cap
-
Website
http://www.innovuspharma.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

2

FDA:2

Drug Approvals

Cetirizine Hydrochloride (Allergy)

Approval Date
Apr 28, 2025
FDA

FLUTICARE

Approval Date
Mar 3, 2025
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

An Open Label Study to Assess the Effect of Euryco-10® Oral Dietary Supplement in Senior Men

Conditions
Healthy Aging
First Posted Date
2020-10-14
Last Posted Date
2020-10-14
Lead Sponsor
Innovus Pharmaceuticals, Inc.
Target Recruit Count
12
Registration Number
NCT04584918
Locations
🇺🇸

San Diego Sexual Medicine, San Diego, California, United States

A Study to Evaluate the Effect and Tolerance of Musclin™ (Thymol) in Healthy Subjects

Not Applicable
Conditions
Healthy Volunteers
First Posted Date
2018-12-06
Last Posted Date
2018-12-06
Lead Sponsor
Innovus Pharmaceuticals, Inc.
Target Recruit Count
20
Registration Number
NCT03767504
Locations
🇺🇸

Palm Beach Research Center, West Palm Beach, Florida, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath